Important and specific role for basophils in acute allergic reactions - PubMed
Review
. 2018 May;48(5):502-512.
doi: 10.1111/cea.13117. Epub 2018 Mar 23.
Affiliations
- PMID: 29431885
- PMCID: PMC5947573
- DOI: 10.1111/cea.13117
Review
Important and specific role for basophils in acute allergic reactions
P Korošec et al. Clin Exp Allergy. 2018 May.
Abstract
IgE-mediated allergic reactions involve the activation of effector cells, predominantly through the high-affinity IgE receptor (FcεRI) on mast cells and basophils. Although the mast cell is considered the major effector cell during acute allergic reactions, more recent studies indicate a potentially important and specific role for basophils and their migration which occurs rapidly upon allergen challenge in humans undergoing anaphylaxis. We review the evidence for a role of basophils in contributing to clinical symptoms of anaphylaxis and discuss the possibility that basophil trafficking during anaphylaxis might be a pathogenic (to target organs) or protective (preventing degranulation in circulation) response. Finally, we examine the potential role of basophils in asthma exacerbations. Understanding the factors that regulate basophil trafficking and activation might lead to new diagnostic and therapeutic strategies in anaphylaxis and asthma.
© 2018 The Authors. Clinical & Experimental Allergy Published by John Wiley & Sons Ltd.
Figures

Basophil activation without evidence of degranulation following oral challenge in peanut‐allergic subjects (n = 4). Blood samples were collected prior to, during and 24 h after objective allergic reaction at oral food challenge, as previously described.50 Surface expression of
CD63 (A) on basophils was evaluated (without further ex vivo stimulation) by flow cytometry.50 Basophils were isolated by Ficoll‐density centrifugation and purified to over 90% purity by immunomagnetic cell sorting, using a negative selection technique which we have previously described.111 Cells were incubated for 15 min at 37°C before stimulation with crude peanut extract (
CPE) or anti‐IgE for 8 min after which histamine release was assessed by spectrofluorometric autoanalysis according to Shore et al 112 (B). Data are shown as mean percentage histamine releases ±
SEM. Despite increased surface
CD63 expression on ex vivo, unstimulated basophils (A), there was no difference in IgE‐mediated histamine release in the same basophils compared with baseline (B). This implies that circulating basophils have become “activated”—or rather, have increased surface expression of
CD63, an activation marker—but with no evidence of degranulation, at least in terms of histamine release. These data presented at the 45th annual meeting of the European Histamine Research Society (
EHRS) in Florence, 2016

Hypothetical role of basophil migration in anaphylaxis. Upon allergen challenge, basophil‐directed chemokine
CCL2 (possibly secreted from mast cells) induces a rapid migration of basophils out of the circulation. This may reactogenic, with migration to target organs resulting in activation and degranulation. Alternatively, the migration may be a protective response, removing basophils from the circulation so that they are unable to degranulate in response to circulating allergen.
CCL2, chemokine (C‐C motif) ligand 2;
CCR2, C‐C chemokine receptor type 2; IgE, Immunoglobulin E; IgE receptor, high‐affinity IgE receptor (Fcε
RI)

Hypothetical role of basophil migration in asthma exacerbation. Following exposure to allergen or respiratory viral infection, basophil chemotactic factors are released in lungs leading to recruitment of basophils from the circulation to the airways where they may contribute to the early asthmatic response. In some patients, a Th2‐type immune response orchestrated by basophils, mast cells and infiltration of eosinophils can cause late asthmatic response, resulting in prolonged swelling of the airway mucosa and aggravating the airway obstruction.
CCL2, chemokine (C‐C motif) ligand 2;
CCR2, C‐C chemokine receptor type 2; IgE, Immunoglobulin E; IgE receptor, high‐affinity IgE receptor (Fcε
RI);
IL‐4, interleukin 4
Similar articles
-
Cianferoni A. Cianferoni A. J Allergy Clin Immunol. 2021 Apr;147(4):1123-1131. doi: 10.1016/j.jaci.2021.02.012. J Allergy Clin Immunol. 2021. PMID: 33832694 Review.
-
Ebo DG, Beyens M, Heremans K, van der Poorten MM, Van Gasse AL, Mertens C, Houdt MV, Sabato V, Elst J. Ebo DG, et al. Curr Pharm Des. 2023;29(3):178-184. doi: 10.2174/1381612829666221025091827. Curr Pharm Des. 2023. PMID: 36284380 Review.
-
Inhibition of IgE-mediated allergic reactions by pharmacologically targeting the circadian clock.
Nakamura Y, Nakano N, Ishimaru K, Ando N, Katoh R, Suzuki-Inoue K, Koyanagki S, Ogawa H, Okumura K, Shibata S, Nakao A. Nakamura Y, et al. J Allergy Clin Immunol. 2016 Apr;137(4):1226-1235. doi: 10.1016/j.jaci.2015.08.052. Epub 2015 Nov 11. J Allergy Clin Immunol. 2016. PMID: 26559325
-
Zhang K, Liu J, Truong T, Zukin E, Chen W, Saxon A. Zhang K, et al. J Immunol. 2017 May 15;198(10):3823-3834. doi: 10.4049/jimmunol.1602022. Epub 2017 Apr 10. J Immunol. 2017. PMID: 28396318 Free PMC article.
-
Eggel A, Baravalle G, Hobi G, Kim B, Buschor P, Forrer P, Shin JS, Vogel M, Stadler BM, Dahinden CA, Jardetzky TS. Eggel A, et al. J Allergy Clin Immunol. 2014 Jun;133(6):1709-19.e8. doi: 10.1016/j.jaci.2014.02.005. Epub 2014 Mar 15. J Allergy Clin Immunol. 2014. PMID: 24642143 Free PMC article.
Cited by
-
Rijavec M, Maver A, Turner PJ, Hočevar K, Košnik M, Yamani A, Hogan SP, Custovic A, Peterlin B, Korošec P. Rijavec M, et al. Front Immunol. 2022 Dec 8;13:1016165. doi: 10.3389/fimmu.2022.1016165. eCollection 2022. Front Immunol. 2022. PMID: 36569939 Free PMC article. Clinical Trial.
-
Castaño N, Kim S, Martin AM, Galli SJ, Nadeau KC, Tang SKY. Castaño N, et al. Lab Chip. 2022 May 3;22(9):1690-1701. doi: 10.1039/d2lc00154c. Lab Chip. 2022. PMID: 35438713 Free PMC article.
-
Atopic dermatitis and food allergy: More than sensitization.
Davis KL, Claudio-Etienne E, Frischmeyer-Guerrerio PA. Davis KL, et al. Mucosal Immunol. 2024 Oct;17(5):1128-1140. doi: 10.1016/j.mucimm.2024.06.005. Epub 2024 Jun 19. Mucosal Immunol. 2024. PMID: 38906220 Review.
-
World allergy organization anaphylaxis guidance 2020.
Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S, Geller M, Gonzalez-Estrada A, Greenberger PA, Sanchez Borges M, Senna G, Sheikh A, Tanno LK, Thong BY, Turner PJ, Worm M. Cardona V, et al. World Allergy Organ J. 2020 Oct 30;13(10):100472. doi: 10.1016/j.waojou.2020.100472. eCollection 2020 Oct. World Allergy Organ J. 2020. PMID: 33204386 Free PMC article.
-
Increased number and activation of peripheral basophils in adult-onset minimal change disease.
Han H, Xu YZ, Liao S, Xiao H, Chen X, Lu X, Wang S, Yang C, Liu HF, Pan Q. Han H, et al. J Cell Mol Med. 2020 Jul;24(14):7841-7849. doi: 10.1111/jcmm.15417. Epub 2020 Jun 8. J Cell Mol Med. 2020. PMID: 32510738 Free PMC article.
References
-
- Knol EF, Gibbs BF. Basophils and antigen presentation: of mice and not men? Allergy. 2012;67:579‐580. - PubMed
-
- Gurzeler U, Rabachini T, Dahinden CA, et al. In vitro differentiation of near‐unlimited numbers of functional mouse basophils using conditional Hoxb8. Allergy. 2013;68:604‐613. - PubMed
-
- Schulman ES, MacGlashan DW, Schleimer RP, et al. Purified human basophils and mast cells: current concepts of mediator release. Eur J Respir Dis Suppl. 1983;128(Pt 1):53‐61. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical